Publications

Developmental Cell

CLIP-170S is a microtubule +TIP variant that confers resistance to taxanes by impairing drug-target engagement

Cancer Discovery

Artificial Intelligence in Cancer Research and Precision Medicine

Nature Communications

A Bayesian machine learning approach for drug target identification using diverse data types

Cell Chemical Biology

A Data-Driven Approach to Predicting Successes and Failures of Clinical Trials

Biorxiv (2019)

Imatinib overrides taxane resistance by selective inhibition of novel CLIP1 variant obstructing the microtubule pore

Biorxiv (2019)

A machine learning approach predicts essential genes and pharmacological targets in cancer

Trends in Pharmacological Sciences (2019) - Science Direct

The Missing Pieces of Artificial Intelligence in Medicine

Biorxiv

Multi-task learning predicts drug combination synergy in cells and in the clinic

AACR 2019

Drug repurposing engine fueled by diverse drug similarity data

Biorxiv (2019)

A Machine Learning Approach Predicts Tissue-Specific Drug Adverse Events

AACR

Abstract 3896: A big data approach to predicting context specific synergistic drug combinations

AACR 2018

Abstract 4957: The novel imipridone ONC212 highly synergizes with the BCL-2 inhibitor ABT-199 in AML and activates orphan receptor GPR132

AACR 2018

Abstract 4874: Receptor pharmacology and anti-cancer activity of selective DRD2/3 antagonist imipridone ONC206

A Computational Approach for Identifying Synergistic Drug Combinations

AACR

Abstract 1563: A machine learning approach to predict platform specific gene essentiality in cancer

PLOS ONE 2017

Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors

Neuro Oncology

EXTH-43. DIFFERENTIATED PHARMACOLOGY OF THE IMIPRIDONE ONC201, THE FIRST SELECTIVE DRD2/3 ANTAGONIST IN CLINICAL NEURO-ONCOLOGY

Science Direct

A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription Factors

PMC

Discovery and clinical introduction of first-in-class imipridone ONC201